← Eichor
Study identifier: NCT05889091 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Condition: Head and Neck Squamous Cell Carcinoma  ·  Sponsor: Memorial Sloan Kettering Cancer Center

PhaseNA
Planned participants12
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to find out whether the fat ALT flap procedure is a safe and practical option for reducing neck morbidity in HNSCC patients following cancer treatment of the neck. Neck morbidity after radiation therapy and surgery includes difficulty swallowing, neck or shoulder pain, stiffness, swelling, or changes to the appearance of the treated area. In addition, the researchers will find out whether the study procedure is effective at reducing neck morbidity and improving quality of life after cancer treatment. The researchers will measure quality of life by having participants answer questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

Evan Matros, MD  ·  646-608-8044  ·  matrose@mskcc.org

Jennifer Cracchiolo, MD  ·  212-639-8420

Always discuss trial participation with your own doctor first.

Locations (1)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05889091